The company will advance the creation and implementation of innovative diagnostic solutions. Credit: Testalize.me on Unsplash.

Gene Biotechnology Enterprises (Gene Bio Medical) has formed a strategic partnership with the Canadian Hub for Health Intelligence and Innovation in Infectious Diseases (HI³) for creating diagnostic solutions.

The partnership is part of an initiative named ‘Pandemic preparedness engaging primary care and emergency departments (PREPARED)’.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Upstream Lab founder and director and the University of Toronto associate professor Dr Andrew Pinto is leading the project.

The project has four-pronged objectives: integrating point-of-care tests, linking patients to trials, improving surveillance and accelerating the creation of diagnostics.

As part of the collaboration, Gene Bio Medical will work with HI³ to focus on commercialising and manufacturing aspects of the project, which intends to involve primary care and emergency departments across six Canadian provinces.

See Also:

For supporting the project’s fourth objective, the company will speed up the creation and implementation of innovative diagnostic solutions.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Gene Bio Medical CEO Jessica Hu said: “We’re proud to collaborate with HI³ and contribute to the PREPARED project. Our continued involvement in initiatives under the CBRF/BRIF program demonstrates our commitment to advancing global health solutions.”

HI3 is one of the five hubs assessing research and development projects for the Biosciences Research Infrastructure Fund (BRIF) and the Canada Biomedical Research Fund (CBRF).

It is a coalition of hospital, academic and research networks, government, industry, not-for-profit and community partners including the University of Toronto.

Gene Bio Medical, which serves as the primary commercial and biomanufacturing partner, works with universities and worldwide partners to revolutionise healthcare.